Astrana Health (NASDAQ:ASTH) Price Target Lowered to $56.00 at Stifel Nicolaus

Astrana Health (NASDAQ:ASTH) had its price target reduced by Stifel Nicolaus from $70.00 to $56.00 in a report released on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Stifel Nicolaus’ price objective would indicate a potential upside of 44.67% from the company’s previous close.

ASTH has been the topic of several other research reports. Robert W. Baird boosted their price target on Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Macquarie raised Astrana Health to a “hold” rating in a research note on Monday, December 16th. Finally, Truist Financial reduced their target price on Astrana Health from $59.00 to $50.00 and set a “buy” rating on the stock in a research note on Monday, January 13th. Two analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $63.00.

Astrana Health Price Performance

Shares of NASDAQ:ASTH traded down $0.38 during trading on Thursday, hitting $38.71. 66,395 shares of the stock were exchanged, compared to its average volume of 332,231. The company has a fifty day moving average price of $35.11 and a two-hundred day moving average price of $45.12. The company has a market cap of $2.18 billion, a PE ratio of 29.78, a P/E/G ratio of 1.50 and a beta of 1.20. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.60. Astrana Health has a 12-month low of $29.08 and a 12-month high of $63.20.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ASTH. Louisiana State Employees Retirement System purchased a new position in shares of Astrana Health during the 3rd quarter worth $1,165,000. NorthCrest Asset Manangement LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth $26,704,000. State of Alaska Department of Revenue acquired a new stake in shares of Astrana Health during the 3rd quarter worth $1,373,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth $35,000. Finally, New York State Teachers Retirement System acquired a new stake in shares of Astrana Health during the 3rd quarter worth $2,515,000. Hedge funds and other institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.